Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-03-02FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ondansetron hydrochloride from Hikma Pharmaceuticals USA Inc., related to a generic product.
-
CLINICAL_TRIALS research · 2015-02-05Clinical Trial Update: Do Pharyngeal Packs During Orthognathic Surgery Reduce Postoperative Nausea and Vomiting [NA]
This entry reports a clinical trial update from China Medical University on whether pharyngeal packs in orthognathic surgery reduce postoper…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Prospective Controlled Trial On Clear Feeds Versus Low Residue Diet After Surgery In Elective Colorectal Surgery Patients [NA]
Clinical trial update for a prospective controlled study comparing clear feeds versus a low-residue diet after elective colorectal surgery; …
-
FDA approval · 2015-01-17FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for ondansetron hydrochloride from Eugia US LLC (ANDA 202599), granting regulatory approval for …
-
FDA approval · 2015-01-15FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for ondansetron filed by PAI Holdings dba PAI Pharma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-15FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Aurobindo Pharma Limited, enabling the generic product to adv…
-
FDA approval · 2015-01-14FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for ondansetron hydrochloride from Chartwell RX, LLC., indicating approval of an additional formulat…
-
FDA approval · 2015-01-12FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for EMEND (fosaprepitant dimeglumine) from Merck Sharp & Dohme LLC, updating its labeling for preven…
-
FDA approval · 2015-01-12FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for EMEND (aprepitant) by Merck Sharp & Dohme LLC, updating the product's labeling and indications.
-
FDA approval · 2015-01-09FDA Approved: ONDANSETRON — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for ondansetron supplied by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (ANDA 0792…
-
FDA approval · 2014-12-31FDA Approved: ONDANSETRON — Supplemental Application (ACTAVIS PHARMA, INC.)
FDA approved a supplemental application for ondansetron from Actavis Pharma, updating the approved product under the existing NDA.
-
FDA approval · 2014-12-21FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approves a supplemental application for ondansetron (generic) by Rising Pharma Holdings, Inc., adding another approved generic version.
-
FDA approval · 2014-12-20FDA Approved: ONDANSETRON — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved a supplemental application for ondansetron hydrochloride (ONDANSETRON) from Taro Pharmaceuticals U.S.A., Inc.
-
FDA approval · 2014-12-20FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
The FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp. (ANDA076780), indicating approval related t…
-
FDA approval · 2014-12-10FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ondansetron by Hikma Pharmaceuticals USA Inc., enabling a generic version of the antiemetic to b…
-
FDA approval · 2014-12-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for metoclopramide from Teva Pharmaceuticals USA, Inc., authorizing changes to the product's labelin…
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride by Fresenius Kabi USA, LLC under an ANDA, allowing continued manufactu…
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (AvKARE)
FDA approved a supplemental application for ondansetron from AvKARE, indicating a regulatory update to this product. The approval confirms c…
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for ondansetron hydrochloride (ANDA) filed by NorthStar Rx LLC.
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for ondansetron hydrochloride (generic) from Fresenius Kabi USA, LLC. This action relates to the…
-
CLINICAL_TRIALS research · 2014-11-11Clinical Trial Update: Incidence of Post-operative Vomitings (POV) After Early Refeeding in Pediatric Day Case Surgery. [NA]
A clinical trial is registered to study the incidence of postoperative vomiting after early refeeding in pediatric day-case surgery; the cur…
-
FDA approval · 2014-10-17FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Natco Pharma Limited)
The FDA approved a supplemental application for granisetron hydrochloride submitted by Natco Pharma Limited, updating the approved generic p…
-
FDA approval · 2014-09-18FDA Approved: GRANISETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for granisetron hydrochloride (granisetron) by Fresenius Kabi USA, LLC to update the labeling.
-
FDA approval · 2014-09-18FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Palonosetron hydrochloride submitted by Cipla USA Inc. under NDA 021372. This action updates…
-
FDA approval · 2014-09-18FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for granisetron hydrochloride by Mylan Institutional LLC under an ANDA.